ALSO NOTED: FDA faces harsh criticism; Will statins be targeted genetically?; and much more...

> The FDA's leadership faced withering criticism yesterday, as experts told a Congressional committee that the agency was underfunded, understaffed, overburdened, and seriously behind the times. Report

> If new research bears out, statins may soon be targeted at patients with a specific genetic variations. Report


> A new study suggests that healthcare CIOs and technology vendors don't understand each others needs very well--and that vendors may be making some very wrong assumptions. FierceHealthIT

> As if questions about the effectiveness of cholesterol meds weren't enough, now research is casting blood pressure remedies into doubt. Report

And Finally... Could this vaccine actually cure drug addiction? Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.